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CONTACT SENSITIZERS*
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Hypersensitivity of the delayed type, typi-
cally resulting from injection of an antigen in
Freund's complete adjuvant, can often he pre-
vented by previous exposure to the same anti-
gen by a different route of administration.
This has been shown with contact sensitizers
(1—7) as well as with other antigens (8—13)
on numerous occasions.
In previous studies (14, 15), we have shown
that the development of contact sensitivity fol-
lowing injection of a sensitizer in complete
adjuvant' can be impaired by previous expo-
sure to the compound by the topical route.
Such topical exposure itself often results in
mild contact sensitivity; thus a precedure
which induces contact sensitivity also results
in unresponsiveness to the sensitizer. (This
unresponsiveness is manifested as an inability
to heighten or renew the sensitivity). A simi-
lar phenomenon in man was described by Klig-
man in 1958 (17).
The present experiments are an exploration
of the temporal relationships between these
two results of topical exposure to a contact
sensitizer. Do unresponsiveness and sensitiv-
ity appear simultaneously, or does unrespon-
siveness appear only after sensitivity has
waned? Does unresponsiveness induced by
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The following abbreviations are used: ND MA:
para-mtrosodimethylaniline; CPT: chlorprothixene("Taractan"); DNCB: 2-4 dinitrochlorobenzene;
DNBSO1: 2,4 dinitrobenzenesulfonate; CPT-F or
N-F: Injection of CPT or ND MA, respectively, in
Freund's complete adjuvant into rear foot-pad.
* From the Department of Dermatology, Uni-
versity Hospital, Ann Arbor, Michigan.It is not essential to use complete adjuvant
with the sensitizing exposure in order to demon-
strate unresponsiveness following percutaneous ex-posure to a sensitizer. If sensitivity to NDMA is
allowed to decline to very low levels, one can dem-
onstrate unresponsiveness to a topical dose of
NDMA which sensitizes controls. After topical ex-
posure to CPT, animals will fail to respond to in-jections of CPT in an aqueous emulsion, as well as
to injections with adjuvant (16).
topical exposure appear suddenly, or does it
develop gradually?
Several workers (3, 4, 11, 12) have noted
that unresponsiveness-inducing exposures to
antigen are most effective if one or two weeks
elapse before the normally-sensitizing injec-
tion is given. If a similar temporal relation-
ship is found in our system, we will have fur-
ther reason to believe that unresponsiveness
induced by topical exposure to a contact sensi-
tizer is the same phenomenon as that seen fol-
lowing intravenous exposure, regardless of the
fact that topical exposure also induces contact
sensitivity, while intravenous exposure does
not.
METHOD5
Subjects were male albino guinea pigs, weighing
200 to 350 g at the start of experiments. In all stud-
ies dealing with this question, including experi-
ments preliminary to those presented, over 850
animals were used.
Sensitizers used were: p-nitrosodimethylaniline
(NDMA) (purchased from Distillation Products)
and chlorprothixene (CPT) (donated by Hoffman-
LaRoche Laboratories). NDMA was applied to the
skin in acetonic solution while CPT was dissolved
in ether.
Application of sensitizers to the skin, whether
for topical exposure or for testing, was accom-
plished by pipetting varying amounts of the com-
pound in acetonic or ether solution onto areas of
skin which had been wax-epilated 48 hr. previously.
For purposes of topical exposure, applications were
made simultaneously to numerous sites: 257
NDMA was applied to each of 7 areas: nape, sac-
rum, umbilical area, and dorsa of 4 paws. CPT
(SOOy) was applied only to the nape, umbilicus,
and sacrum. (Such distribution of the topical ex-
posure appears to reduce the variability of results).
In most experiments, animals were finally chal-
lenged with injections into a rear footpad of SOy
NDMA or 1 mgm CPT mixed with 0.1 ml of com-
plete Freund's adjuvant (Difco). NDMA was dis-
solved in acetone before being added to the adju-
vant, which was thus modified by the addition of
.01 ml acetone per .1 ml solution injected. In some
experiments, Freund's complete adjuvant was in-
jected alone.
The degree of sensitivity produced was assayed
by skin tests, which were also conducted on wax-
epilated skin. Two tests were simultaneously ap-
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plied, 25y and lOy NDMA dissolved (0.1%) in
acetone, or SOy and 207 CTP dissolved (02%) in
ether, being pipetted onto two circular areas of
skin 1 cm in diameter.
Test reactions were evaluated 24 hours after ap-
plication of the test dose according to the following
scale:
0—No reaction
0.5—Minimal reaction
1.0—Erythema of part of test area
2.0—Erythema of entire test area or erythema
induration of part of area
3.0—Erythema and induration of entire test area
3 .5—Erythema, induration, and vesiculation
In all cases, these tests were read by two persons
who were unaware of the previous treatment of the
animals being read. In addition, one of the "blind
observers" was a technician who had no knowledge
of the purpose of the experiment. Scores of both
observers were always in essential agreement. As
two tests (e.g.: to 107 and to 257 NDMA) were
always performed simultaneously, a total score was
derived for each animal on each testing session by
adding the two 24-hour readings. Thus, total scores
(the "sensitivity scores" presented in the figures)
ranged from 0 to 7. Statistical analysis was car-
ried out by means of the Mann-Whitney "U"
test, a simple non-parametric test.
RESULTS
Porodigmaf Ic experiment. Most of our studies
involve three steps:
1. "Topical exposure". The contact sensitizer
is simultaneously applied to multiple skin
areas.
2. "Sensitizing injection". The sensitizer,
mixed with Freund's complete adjuvant, is
injected into a foot-pad. (While topical ex-
posure to many compounds (eq.: NDMA,
but not CPT) produces a mild contact sen-
sitivity, injection of either NDMA or CUT
in complete adjuvant produces a strong
sensitivity). The interval between steps 1
and 2 is the major variable being manipu-
lated in these studies; in some eases topical
exposure was given offer, rather than be-
fore the sensitizing injections.
3. "Testing". Epicutaneous tests were con-
ducted at varying intervals after the sen-
sitizing injection. The reactions to such
tests reflect to varying degrees the follow-
ing four phenomena:
A. The immunologic "response" to the sen-
sitizing injection. This is the dependent
variable of primary interest.
B. Contact sensitivity appearing in re-
sponse to the topical exposure alone. In
the case of NDMA, this reaches a peak
10—15 days after topical exposure, and
thereafter declines.
C. "Neutralization", or hyposensitization of
the response to the sensitizing injection
by topically applied sensitizer which re-
mains on the skin. This phenomenon is
especially apparent when the topical ex-
posure is given after the response to the
sensitizing injection has appeared.
D. "Potentiation" of the response to the
sensitizing injection by topical exposure
to the compound near the time of injec-
tion.
These phenomena are represented diagramati-
cally in Figure 1.
I. Par fbi unresponsiveness appearing simui-
foneousiy wifh contact sensitivity. In Figure
2 are presented "blind" test readings which re-
sult when topical exposure (25 y NDMA ap-
plied to each of 7 areas) is given 3 days before
and 1 day after the sensitizing injection (see
legend).
These two groups are to be compared with
animals exposed topically 10 days after the in-
jection. Sensitivity to NDMA is usually fully
deveolped by the tenth day fter injection, at
which timc topical exposure can be shown to
produce a sharp drop in sensitivity, as well as
a brisk response at the sites of application.
Hence the decrease in sensitivity scores of the
animals exposed topically on day +10 as com-
pared to unexposed controls is due to neutrali-
zation phenomena, and not to unresponsive-
ness. (Analogous neutralization phenomena
have been investigated elsewhere (3, iS).) As
it is conceivable that sensitizer put on the
skin early in the experiment might still be
present in sufficient quantity to neutralize
sensitivity when it appears, we can only at-
tribute to unresponsiveness a greater drop in
sensitivity.
Such a greater drop is seen in the scores pre-
sented in Figure 2, as scores of the animals ex-
posed topically on days —3 and +1 are lower
than those of animals exposed on day +10.
Statistical comparison of the scores of the
"—3" and "+10" groups confirms the reliabil-
ity of the difference between them (P < .01).
When NDMA is applied topically one day
offer the sensitizing injection, sensitization
was similarly inhibited. The difference in
scores of the "+1" and "+10" groups in the ex-
periment presented fell just short of statistical
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reliability (.06 > P > .05), but in two earlier
experiments with NDMA wbieh involved a to-
tal of 47 guinea pigs distributed between these
two groups, statistically significant differences
between their blindly read scores were seen
(P < .01 in both cases). (The animals pre-
sented in figure 2 were also tested on day +13,
at which time the same trends, but with
slightly higher scores, were seen).
It is clear then that the response to a sensi-
tizing injection of NDMA can be partially
inhibited by topical application of the same
sensitizer even one day later. Induction of un-
responsiveness by intravenous administration
of a sensitizer one day after a sensitizing in-
jection has also been reported by Sulzbcrger
(1) and a similar phenomenon in a protein an-
tigen system has recently been described both
by Dvorak and Flax (19) and by Asherson and
Stone (11).
II. Later development of complete unrespon-
siveness. Although the response to NDMA in
complete adjuvant is significantly inhibited
by topical exposure either 1 day after or 3 days
before the injection, this inhibition is not al-
ways complete. This is illustrated by the ex-
pcriment presented in Figure 3, in which the
response to topical exposure followed by injec-
tion of NDMA in complete adjuvant is com-
pared with that to topical exposure followed
by an injection of adjuvant alone.
It is apparent from these data that when
NDMA in adjuvant is injected 3 days after
topical exposure, there is some increase in con-
tact sensitivity above that resulting from in-
jection of adjuvant alone (P < .05). If we wait
11 days for the injection, however, there is no
response at all. In other experiments of the
same design, unresponsiveness was found to be
incomplete at 2 days, but complete at 13 days;
at 5 and 7 days results were variable from one
experiment to another.
When an injection of complete adjuvant
alone is given several days after topical expo-
sure to NDMA, some heightening of sensitiv-
ity relative to that seen in uninjectcd animals,
is noted. If one wishes to consider this also to
be a partial "response", then a very small de-
gree of responsiveness probably remains even
10 days after topical exposure (14).
Thus, topical application of NDMA can in-
hibit the response to the same compound in-
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Fm. 1. Schematic representation of development of unresponsiveness (represented in-
versely by solid line) following topical exposure to a contact sensitizer, and of other phe-
nomena which may also influence test results. (Representation of neutralization and po-
tentiation, and of unresponsiveness beyond day +1 is approximate.)
jected with Freund's complete adjuvant even if
it is given as late as 24 hours after the injec-
tion. If the injection follows topical exposure,
response to it is even more impaired, and as
the interval between exposure and injection is
increased beyond one or two weeks, this inhi-
bition becomes complete. This curve is repre-
sented in Figure 1.
However, the apparent failure of topical ex-
posure to completely inhibit the response to
injection given within 3 days can conceivably
be interpreted in terms of the phenomenon of
potentiation, which is described below.
III. "Potentiation" of sensitization by topi-
cal application of the sen.sitizer. When CPT
was used as a sensitizer, a similar curve was
found: the usual response to an injection of
CPT in complete adjuvant was impaired by
topical application of CPT even 1 day after
the injection and nnresponsivencss appeared to
become more complete with the passage of time
between topical exposure and injection. Thus,
in one experiment involving 43 guinea pigs,
animals exposed to CPT by the topical route 6
days before injection showed no response at
any time; those exposed on days —2, —1, or
+ 1 when tested 20 days after the sensitizing
injection showed moderate sensitivity, but
significantly less than those exposed on day
+10.
On an earlier test (on day +11), however,
sensitivity scores of the same "—2", "—1", and
"+1" animals were equal to those of the "+10"
or unexposed control groups. Topical exposure
to CPT at these intervals appears to have
shortened the duration of response to the in-
jection more than it prevented it.
This, as well as other experiences, suggested
that topical exposure to CFT may transiently
potentiate the response to injection of that
compound in Freund's complete adjuvant if
the injection is given at about tbe same time.
Thus, failure to completely inhibit the devel-
opment of sensitivity by topical exposure just
before or just after injection of the sensitizer
in adjuvant may not be due to the need for a
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Fm. 2. Effects of topical exposure to NDMA on contact sensitivity resulting from in-jection of NDMA in complete Freund's adiuvaat ("NF"). Each dot represents the 24-hour
sensitivity score of one guinea pig on the final test. Medians are represented by triangular
marks. Control animals (last column) show response to NF alone, while animals given
topical exposure 10 days after the injection (third column) show some degree of neutraliza-
tion. Topical exposure 3 days before or 1 day after the iniection (first two columns) re-
sulted in even lower sensitivity scores, due to impaired response to NF.
few days to elapse for the inhibitory machin-
ery to develop. It is also possible that this ma-
chinery is quite rapidly set in motion, but
that is simply overwhelmed when the impetus
to sensitization is augmented by topical expo-
sure given near the time of injection.
An experimental investigation of this po-
tentiation phenomenon is presented in Figure
4, in which sensitivity scores of the same ani-
mals on two successive tests are presented. In
this experiment, the response to an injection
of CPT in adjuvant was compared to the re-
sponse to the injection plus topical exposure at
about the same time (12 hours before and 24
hours after). This comparison was made both
in animals made unresponsive by topical ex-
posure 6 days before the injection (the first 3
groups) and in normal animals (last 3 groups).
These test results yield definite evidence for
a potentiation effect:
1) Animals given a single topical exposure
just before or just after injection may briefly
become as sensitive as , or perhaps more sensi-
tive than, controls given the injection alone
(as opposed to the partial unresponsiveness
seen on the second test 9 days later).
2) Unresponsiveness induced by topical ex-
posure 6 days prior to injection can be par-
tially overcome when, in. addition to the expo-
sure on day —6, a second topical exposure is
given either just before or just after the injec-
tion. (This effect was seen in 7 of 16 animals.)
It should be noted that CPT does not induce
sensitization when applied topically. In spite
of this, a potentiation effect is seen. This
opens the possibility that some degree of po-
tcntiation may appear in studies in which un-
responsiveness is induced by intravenous ad-
ministration of antigen.
However, it is important to note that the
break-through induced by the second topical
exposure near the time of injection was not
complete, and hence cannot account for the
great increase in unresponsiveness between the
first and sixth day after topical exposure. (If
there were no such increase in unresponsive-
ness, the scores of all animals given topical
exposure on days —1,4 or +1 would have been
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FIG. 3. Symbols same as in Fig. 2. Symbol "F" indicates injection of complete adjuvant
alone, and scores of animals in columns 2 and 4 represent sensitization due to topical ex-
posure and later injection of adjuvant. It is apparent that when a sensitizing iojection was
given 3 days after topical exposure to NDMA, a partial response, or heightening of sensi-
tivity occurred. When the sensitizing injection was given eleven days after topical ex-
posure, however, there was no further response.
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equally high, regardless of previous topical be the reverse of unresponsiveness, or "nega-
exposure on day —6. That is, scores in columns tive unresponsiveness". Because it is a more
2 and 3 of Figure 4 would have been as high as transient effect than unresponsiveness, we have
those in columns 4 and 5.) Thus we have still preferred to designate it separately.
further net evidence that the degree of unre-
sponsiveness gradually increases after topical DISCUSSION
exposure to a contact sensitizer. From these experiments it is obvious that
There is no semantic reason why this poten- application of NDMA to the skin of the
tiation effect cannot simply be considered to guinea pig sets in motion two phenomena,
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DAY 0 CPT—F CPT—F CPT—F CPT—F CPT—F CPT—F
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FIG. 4. Scores of same animals on two successive tests, representing the degree of sensi-
tivity following injection of CPT in Freund's complete adjuvant on day 0. Topical ex-
posure 12 hrs before or 24 hrs after sensitizing injection appears to potentiate the response,
partially over-riding the almost complete inhibition of response induced by topical ex-
posure 6 days before injection. When tested a second time, 18 days after the injection,
this potentiation effect had disappeared, and impairment of sensitivity was noted in all
topically exposed animals.
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contact sensitization and unresponsiveness to
further contact sensitization; and that these
two processes simultaneously develop over the
following two weeks. In contact sensitivity,
sensitization and unresponsiveness are not
mutually exclusive processes, for both can oc-
cur at the same time. Nor do they appear
to he two manifestations of the same process,
for unresponsiveness can appear alone when
the sensitizer is given by a different route, or
(in the case of CPT) even when it is put on
the skin.
The rate at which unresponsiveness devel-
ops after topical exposure to NDMA is very
similar to that seen after intravenous exposure
to DNBSO2 (3), or after non-sensitizing ex-
posure to other antigens (11, 12) : it takes
1 to 2 weeks to develop complete responsive-
ness, though some degree of responsiveness is
apparent at once. (Such a curve was not de-
scribed by Dvorak and Flax (19), however.)
This is a further argument that these instances
of unresponsiveness to delayed-hypersensitiv-
ity-inducing procedures reflect the same under-
lying mechanism, regardless of the route of
administration of the antigen. Most investi-
gators of unresponsiveness in other systems
(e.g.: 20) have attributed the phenomenon to
cellular, rather than to humoral mechanisms.
As Ashcrson (11) has pointed out, it would
be folly to assume that an animal which can
no longer develop a delayed allergic reaction
is completely unresponsive: other immuno-
logic phenomena may occur and probably do.
The relative ease with which delayed skin re-
actions (as opposed to certain other immuno-
logic responses) are prevented by prior ex-
posure to the antigen has also been noted by
others (19).
Our experience may be summarized by
saying that the guinea pig tends to develop
contact sensitivity, if he is going to at all,
the first time he is exposed to the sensitizer.
Several days later, his response to the old
antigen has changed, and contact sensitivity
can no longer be elicited. This conclusion is
quite reminiscent of Kligman's 1958 comment
on poison ivy sensitivity in man: "booster
effects are not characteristically realized" (17).
This is somewhat analogous to the tendency
for 19-S antibodies to be produced following
initial exposure to an antigen, but not as a
secondary response.
The fact that a delayed allergic response can
be partially inhibited by additional exposure
to antigen 1 day after sensitization (or even
later (11, 19)) suggests that the process of
sensitization is blocked at some intermediate
step.
We have no idea what goes on during the
days required for unresponsiveness to become
established, just as we do not know why it
takes several days for contact sensitivity to
develop. This time is not required for dis-
semination of the compound throughout the
body, for a similar delay in the development
of unresponsiveness has been described after
intravenously administered antigen (3, 4).
We can only imagine that at some secondary
step in the course of sensitization the ani-
mal has a limited capacity to handle a given
antigen. Several days after topical exposure to
a sufficient amount of NDMA this capacity is
pre-emp ted and committed to development of
a weak contact sensitivity; while after topi-
cal CPT, enteric NDMA (15), or intravcnons
DNCB this mechanism is committed at about
the same time to a path resulting in no detect-
able contact sensitivity to the antigen.
SUMMARY
When NDMA is put on the skin of a
guinea pig, the animal develops a mild sensi-
tivity to the compound, but also becomes un-
responsive to efforts to increase or renew this
sensitivity by injection of NDMA in com-
plete adjuvant. In a series of experiments,
this refractoriness to further sensitization, or
unresponsiveness, was found to require 1—2
weeks for complete development; attempts to
heighten sensitivity at shorter intervals after
topical exposure were partially successful, and
as the interval between topical exposure to
NDMA and its injection in adjuvant de-
creased, the degree of unresponsiveness dimin-
ished. Some degree of unresponsiveness could
be induced by topical application of the sen-
sitizer even 1 day after the sensitizing in-
jection.
Thus, unresponsiveness and sensitization
develop over the same period of time after the
first topical exposure to the sensitizer.
The temporal relationships observed in these
experiments arc quite similar to those seen
in other systems in which the development of
delayed hypersensitivity is prevented by
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previous exposures to the antigen which do
not of themselves induce sensitization. This
is evidence that the process of unresponsive-
ness which is initiated by exposure to the
antigen is the same, whether sensitization takes
place or not.
These experiments lend themselves to the in-
terpretation that contact sensitivity may be
induced by the first exposure to an antigen,
but, in the guinea pig, it is not induced or
increased by a second exposure as much as
2 weeks later. In this tendency to occur as a
primary, but not as a secondary response, con-
tact sensitization, and probably certain other
forms of delayed hypersensitivity, resemble
the 19-S antibody response.
Interpretation of the data is complicated by
sensitization due to topical exposure to NDMA
itself, by the appearance of potentation phe-
nomena, and by neutralization phenomena (by-
posensitization).
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